Recent Price Movement and Market Context
The stock has experienced a consecutive three-day decline, shedding 7.32% over this period. Today’s fall of 1.58% further extended its underperformance, lagging the FMCG sector by 1.07%. Procter & Gamble Hygiene & Health Care Ltd. is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum.
In comparison, the Sensex opened 323.83 points higher but reversed sharply to close down 395.64 points at 75,431.04, reflecting a cautious market environment. The benchmark index itself is trading below its 50-day moving average, which is positioned beneath the 200-day moving average, indicating a bearish trend in the broader market.
Long-Term Performance and Valuation Metrics
Over the past year, Procter & Gamble Hygiene & Health Care Ltd. has delivered a negative return of 26.07%, considerably underperforming the Sensex, which posted a positive 1.69% return in the same period. The stock’s 52-week high was Rs. 14,536.60, underscoring the extent of the recent decline.
Despite this price weakness, the company’s profits have risen by 20.1% over the last year. However, the price-to-earnings-to-growth (PEG) ratio stands at 1.9, suggesting that the stock’s valuation may not fully reflect its earnings growth potential. The company’s return on equity (ROE) is notably high at 92.3%, yet it carries an expensive valuation with a price-to-book value of 35.5. This valuation is discounted relative to its peers’ historical averages, indicating some market scepticism.
Financial Growth and Profitability Trends
Over the last five years, the company’s net sales have grown at an annual rate of 5.52%, while operating profit has increased at 5.34% annually. These moderate growth rates have contributed to the stock’s subdued performance. The company maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure.
Recent quarterly results showed the highest net sales at Rs. 1,261.90 crores and PBDIT at Rs. 401.80 crores. The profit after tax (PAT) for the nine months ended December 2025 stood at Rs. 703.38 crores, growing by 25.26%, highlighting operational profitability despite the stock’s price decline.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Technical Indicators and Market Sentiment
Technical analysis reveals a predominantly bearish outlook. The Moving Average Convergence Divergence (MACD) indicator is bearish on both weekly and monthly charts. Bollinger Bands also signal bearish momentum over these timeframes. The daily moving averages confirm this trend, with the stock trading below all key averages.
The KST (Know Sure Thing) indicator is bearish on weekly and monthly scales, while Dow Theory assessments suggest a mildly bearish stance. The Relative Strength Index (RSI) and On-Balance Volume (OBV) indicators show no clear signals or only mild bullish tendencies on monthly charts, indicating limited buying pressure.
Comparative Performance and Market Positioning
Procter & Gamble Hygiene & Health Care Ltd. has consistently underperformed the BSE500 index over the past three years, with negative returns each year. This trend highlights the stock’s challenges in keeping pace with broader market gains. The company is classified as a mid-cap stock within the FMCG sector, with promoters holding the majority shareholding.
Despite the stock’s current valuation discount relative to peers, its long-term growth rates and recent price action have contributed to a downgrade in its Mojo Grade from Hold to Sell as of 17 October 2024, with a Mojo Score of 44.0.
Why settle for Procter & Gamble Hygiene & Health Care Ltd.? SwitchER evaluates this FMCG mid-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Key Metrics
The stock’s current price of Rs. 10,020.55 represents a significant decline from its 52-week high of Rs. 14,536.60. The company’s financial metrics show moderate sales and profit growth, a high ROE of 92.3%, and a conservative debt profile. However, the valuation remains elevated with a price-to-book ratio of 35.5, and the stock’s performance has lagged behind both sector and benchmark indices over multiple periods.
Technical indicators reinforce the bearish sentiment, with the stock trading below all major moving averages and exhibiting negative momentum across several trend-following tools. The downgrade in Mojo Grade to Sell reflects these combined factors.
Market Capitalisation and Shareholding
Procter & Gamble Hygiene & Health Care Ltd. is classified as a mid-cap company within the FMCG sector. The majority shareholding is held by promoters, which typically provides stability in ownership structure. The company’s low debt-to-equity ratio of zero further supports a conservative financial stance.
Recent Quarterly Highlights
The company reported its highest quarterly net sales of Rs. 1,261.90 crores and PBDIT of Rs. 401.80 crores in the latest quarter. The nine-month PAT of Rs. 703.38 crores reflects a 25.26% increase, indicating profitability improvements despite the stock’s price decline.
Conclusion
Procter & Gamble Hygiene & Health Care Ltd.’s stock has reached a new 52-week low amid a challenging market environment and persistent underperformance relative to benchmarks and peers. While the company demonstrates solid profitability and conservative financial management, its valuation and price trends have led to a cautious market stance. The technical indicators and recent downgrade in rating underscore the current market sentiment surrounding the stock.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
